Biotech · Private company · Indianapolis, IN, US
Nerx Biosciences, Inc.
Track this companyFree. Adds Nerx Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapyFiscal year 2025 · $921.3KNIH RePORTER 5R44CA287693-02 · fetched Nov 12, 2026
- Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapyFiscal year 2024 · $1.1MNIH RePORTER 1R44CA287693-01A1 · fetched Nov 12, 2026